
Marco Claasen
@claasen_m
Followers
90
Following
114
Media
1
Statuses
15
MD | Research Fellow Liver Transplantation @UHN | PhD Candidate Transplant Oncology @ErasmusMC | Resident Surgery @asznl
Toronto, Ontario
Joined May 2022
RT @acsJACS: A new JACS study found an interim analysis of a prospective living donor liver transplant trial provides insight into the traj….
0
8
0
RT @EASLnews: Today’s #readoftheweek📚 explores why standardization of therapeutic strategies for combined hepatocellular-cholangiocarcinoma….
0
11
0
RT @shwaartz: *Research fellow position*.Looking for a committed, post doc research fellow with an MD for a 2-year position at Toronto gene….
0
29
0
RT @ivanics_t: Machine learning–based mortality prediction models using national liver transplantation registries are feasible but have lim….
0
3
0
RT @ESOTtransplant: 📢 Our aim is to reach a consensus, and a better homogeneity between centres and networks. w/ @ChristianToso, @claasen_….
0
6
0
RT @EASLnews: Hot off the press from @JHepatology: Living donor #transplantation offers a safe alternative for liver transplant patients. R….
0
10
0
RT @JHepatology: 🆕Article in press❕. Low utilization of adult-to-adult #LDLT in Western countries despite excellent outcomes: International….
0
4
0
RT @ArndtVogel: 🔥Comprehensive overview on living donor liver transplantation🔥.@HEP_Journal. 👉Canada: 19.5%; US: 3.….
0
15
0
RT @JHepatology: 🆕Article in press❕. Nestin as a diagnostic and prognostic marker for combined #hepatocellular-#cholangiocarcinoma. Read it….
0
27
0
RT @UHNTransplant: Congratulations to the 2022 Transplant Fellowship Competition winners. ▪️ Samrat Ray.▪️ Laura Walti.▪️ Javier Tomas S….
0
4
0
RT @DJPinato: #MarcoClaasen presents data on transplant in fibrolamellar #HCC @EASLnews @LorenzaRimassa @Alexfornergon .
0
2
0
RT @massimoiava: @claasen_m presenting at #ILC2022 data on #liver #transplant for #fibrolamellar #HCC high recurrence rate but we do not kn….
0
2
0
RT @AnnSurgOncol: Systematic Review and Meta-Analysis of Prognostic Factors for Early Recurrence in #Intrahepatic #Cholangiocarcinoma After….
0
17
0
Looking back with pleasure on @_ILTS_ 2022 #Istanbul. Great conference, proud to have contributed through a presentation on #LT for cHCC-CCA. Special thanks to @dewojt @sapisochin @ivanics_t Jan IJzermans for all the great support! On to next year's conference in #Rotterdam!
0
1
10